Provider review
REMEVi review
Names four pharmacies directly — but its own pages disagree on 503A vs 503B.
Its homepage states an unhedged "503A" claim naming four specific pharmacies with a vial-label transparency pitch, but its own tirzepatide-page FAQ separately states its semaglutide is compounded by a "503B outsourcing facility" — a real, unresolved contradiction about its own regulatory sourcing.
Transparency scorecard
2 of 4 disclosed openly
What REMEVi discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
What it actually costs
What they advertise
Tirzepatide: "$319/mo" (no commitment), "$249/mo" (12-week prepay), "$199/mo" (52-week prepay). Semaglutide: "$219/mo", "$189/mo" (12-week), "$149/mo" (52-week) — an oral option also exists at "$349/mo" or "$249/mo" (52-week). Sermorelin: "$145 / 4 wks · all-inclusive," a single price with no tiers.
What you actually pay, month to month
$319/mo (tirzepatide), $219/mo (semaglutide) — both REMEVi's own stated no-commitment monthly rate, disclosed beside the prepay tiers on the same page. $145 per 4 weeks (sermorelin) — REMEVi's own single stated price for that product, on a 4-week rather than calendar-month cadence.
The commitment trap
Not a hidden trap for tirzepatide or semaglutide: REMEVi's own product pages state the no-commitment monthly rate directly beside the 12-week and 52-week prepay tiers, on the same page. Sermorelin's "per 4 weeks" framing, distinct from the GLP-1 products' "/mo" language on the same site, is worth a reader's attention even though REMEVi doesn't call it a discount or a promo.
Checked live on REMEVi's own site at https://remevihealth.com/tirzepatide in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off REMEVi's own public pages on the date shown, not from a third-party comparison table.
The bottom line
REMEVi LLC sells compounded tirzepatide, compounded semaglutide, and compounded sermorelin through a bilingual (English/Spanish) telehealth storefront licensed in all 50 states plus DC. Its homepage makes the single most specific pharmacy disclosure of this round's six additions — "Named pharmacy on every label 503A," with four pharmacies named directly by city and state, plus a genuinely checkable LegitScript seal (ID 50384507, confirmed live). That specificity doesn't survive a second page: its own tirzepatide FAQ states, about semaglutide, that it's compounded by a "503B outsourcing facility" — an unhedged 503A claim on one page and an unhedged 503B claim on another, the same self-contradicting shape already found elsewhere on this roster for Welling Health.
REMEVi appears on our sermorelin provider ranking, our tirzepatide provider ranking and our semaglutide provider ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want a real, checkable LegitScript seal — REMEVi's (ID 50384507) independently resolves against LegitScript's own CDN
- You want to see multiple named fulfillment pharmacies with city/state, even though their regulatory category is disputed on the site's own pages
- You want a real, unhedged "all 50 states + DC" claim with no exclusion list
Look elsewhere if
- You want a single, confident, uncontradicted regulatory-category claim — REMEVi's own pages disagree with each other
- You want sermorelin billed on the same monthly cadence as its GLP-1 products — sermorelin is billed "per 4 weeks," not "/mo"
- You'd rather avoid a fulfillment network that overlaps with pharmacies this roster's own research has separately flagged for a candidate it chose not to pursue further (Get Thin MD)
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what REMEVi bundles in, and what it does not.
Clinician consult
Included; described as reviewed by a licensed provider before a…
prescription routes to a pharmacy.
Bloodwork / labs
Not stated on the pages checked.
Follow-ups and dose changes
Not itemized beyond the standard subscription model.
Human support
None named beyond "bilingual care coordination
" No dietitian, nurse, or structured coaching role is named.
Injection supplies
Described generally as included ("all-inclusive") for…
sermorelin; not itemized for the GLP-1 products.
Shipping
Monthly shipping described as included for sermorelin…
("all-inclusive"); not itemized separately for the GLP-1 products.
Who fills it, and who's watching
The pharmacy
Unknown, despite a confident-sounding homepage claim. Its own homepage states, unhedged, "Named pharmacy on every label 503A," naming RedRock Pharmacy (St. George, UT), Health Warehouse (Florence, KY), Precision Medicine (Bellmore, NY), and Triad Rx (Daphne, AL) directly. But its own tirzepatide page's FAQ states, about semaglutide specifically, "REMEVi's semaglutide is compounded by a 503B outsourcing facility registered with the FDA" — a real, unresolved contradiction between an unhedged 503A claim on one page and an unhedged 503B claim on another, so this stays "unknown" rather than crediting either.
Oversight
Included; described as reviewed by a licensed provider before a prescription routes to a pharmacy. Not itemized beyond the standard subscription model.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.
Where you can get it
All 50 states plus DC, unhedged. Its own site states, "Licensed in all 50 states + DC," repeated in multiple places. No exclusion list found.
The honest cons
The part they would rather you skipped
REMEVi's own tirzepatide page contradicts its own homepage: the homepage states an unhedged "503A" claim covering every named pharmacy ("Named pharmacy on every label 503A"), while the tirzepatide page's own FAQ states, about a different product on that same page, that semaglutide specifically "is compounded by a 503B outsourcing facility." A reader cannot tell from REMEVi's own site which category actually applies. Separately, two of the four named pharmacies (RedRock Pharmacy, Triad Rx) are also two of the four this roster's own resolution log already named while evaluating (and choosing not to pursue) Get Thin MD — a shared white-label vendor pattern already documented elsewhere on this roster (Vytora Health, Rylo Health, and PepHaūs all share vendors too) and not itself disqualifying, but worth knowing given the surrounding contradiction.
- Homepage states an unhedged 503A claim; its own tirzepatide-page FAQ states an unhedged 503B claim for semaglutide — a real, unresolved self-contradiction.
- Sermorelin is billed "per 4 weeks," a different cadence than the GLP-1 products' "/mo" framing on the same site.
- Two of its four named pharmacies overlap with a vendor network this roster's own research has separately flagged for a different, unpursued candidate.
- Refunds are limited to medical disqualification or a damaged/incorrect shipment, per its own policy — standard for this roster, but worth stating.
None of this is unique to REMEVi — the whole category shares it.
How it compares
The providers we rank on our sermorelin provider ranking — the most specific board REMEVi sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- Strut HealthAn FDA warning letter over labeling, plus an auto-refill price on every product.
- EHEOS HealthNames five 503A pharmacies — but its own legal pages disagree on HIPAA.
- PLPlexusDxPriciest starting-price seller; the only one admitting it's not FDA-approved.
- PRPreventiveMDShows every price tier in one table — but its own headline is the cheapest one.
- StackMDReal dose-tier pricing — but its sermorelin page quotes a price nothing sells at.
- PSPepHaūsThe only provider on this roster to name a pharmacy AND state 503A on the same page.
- Precision TelemedNames its actual compounding pharmacy directly on its own product pages.
- YOYourHealthRxDiscloses a first-month promo — but its own homepage still quotes it as standing.
19 more providers rank on our sermorelin provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect REMEVi's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on REMEVi's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.